Physician profile
Minal Patel
NPI 1891136784
$1,391.78
in general payments reported to CMS, 2019-2025
17 companies · $488 in 2025
The $488 reported for 2025 was more than what a typical Sleep Medicine (Pediatrics) provider received nationally (typical 2025 total: $235).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.73 · 2020: $54.42 · 2021: $178 · 2022: $88.21 · 2023: $135 · 2024: $406 · 2025: $488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $973 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $972.98 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $614.20 | 2019-2025 | Xywav, Epidiolex |
| Harmony Biosciences LLC | $253.94 | 2024-2025 | |
| Inspire Medical Systems, INC. | $123.91 | 2025 | Inspire |
| Nobelpharma America, LLC | $83.51 | 2024 | |
| Collegium Pharmaceutical, INC. | $66.47 | 2025 | Jornay Pm |
| Ucb, INC. | $43.34 | 2024 | Fintepla, Briviact |
| Resmed Corp | $35.28 | 2023 | |
| Sk Life Science, INC. | $24.63 | 2024 | |
| Lilly USA, LLC | $23.02 | 2025 | Zepbound |
| Pharming Healthcare, INC. | $19.84 | 2024 | Ruconest |
| Otsuka America Pharmaceutical, INC. | $18.16 | 2021 | |
| Aucta Pharmaceuticals, INC. | $15.28 | 2024 | Motpoly Xr |
| Tris Pharma INC | $15.08 | 2025 | Dyanavel Xr |
| Otter Pharmaceuticals, LLC | $14.79 | 2024 | Sympazan |
| Vertical Pharmaceuticals, LLC | $14.43 | 2025 | Relexxii |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $14.21 | 2023 | Methylphenidate Hydrochloride |
| Amgen INC. | $11.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Minal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.